ClassID:

96740

C07K7/08 - page 8 - CPC Classification

Classification description:

Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof; Linear peptides containing only normal peptide links having 12 to 20 amino acids

Recent Application in this class:
#2101
20170296647
2017-10-19

Prophylactic protection against viral infections, particularly HIV

#2102
20170291923
2017-10-12

Antibacterial cyclic lipopeptides

#2103
20170291922
2017-10-12

Delta receptor agonist peptides and use thereof

#2104
20170291918
2017-10-12

METHOD FOR PURIFYING PROTEIN

#2105
20170290897
2017-10-12

Peptides and combination of peptides as targets or active ingredients for use in immunotherapy against AML and other cancers

#2106
20170283467
2017-10-05

Programmable polypeptide and nucleic acid nanoparticles

#2107
20170283463
2017-10-05

Immunomodulators

#2108
20170283461
2017-10-05

CELL-REACTIVE, LONG-ACTING, OR TARGETED COMPSTATIN ANALOGS AND RELATED COMPOSITIONS AND METHODS

#2109
20170283460
2017-10-05

Immune System Modulation for Prophylaxis and Treatment of Diseases and Disorders

#2110
20170283459
2017-10-05

Peptide inhibitors of calcium oxalate monohydrate crystallization and uses thereof

#2111
20170283458
2017-10-05

COLLAGEN-BINDING SYNTHETIC PEPTIDOGLYCANS FOR WOUND HEALING

#2112
20170283457
2017-10-05

Use of inhibitory peptides for the treatment of inflammatory diseases

#2113
20170281774
2017-10-05

LINACLOTIDE COMPOSITIONS

#2114
20170281720
2017-10-05

Peptidomimetic macrocycles

#2115
20170280761
2017-10-05

METHOD TO CONCENTRATE APOA-1 MIMETIC PEPTIDES TRANSGENICALLY EXPRESSED IN PLANTS

#2116
20170275336
2017-09-28

Peptide and use thereof

#2117
20170275335
2017-09-28

IMPROVED PROCESS FOR PREPARATION OF AMORPHOUS LINACLOTIDE

#2118
20170275333
2017-09-28

NOVEL PEPTIDE COMPOSITIONS

#2119
20170269079
2017-09-21

Mycobacterium Antigens

#2120
20170269078
2017-09-21

Method of detecting auto-antibodies from patients suffering from rheumatoid arthritis, a peptide and assay kit

#2121
20170269077
2017-09-21

Peptide microarrays and novel biomarkers for celiac disease

#2122
20170267723
2017-09-21

Peptides for treating bone diseases and use thereof

#2123
20170267722
2017-09-21

Inhibitory peptides of viral infection

#2124
20170266306
2017-09-21

TARGETED ANTIMICROBIAL MOIETIES

#2125
20170260274
2017-09-14

Construct for the delivery of a molecule into the cytoplasm of a cell

#2126
20170260237
2017-09-14

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

#2127
20170260236
2017-09-14

Compositions for expanding regulatory T cells (TREG), and treating autoimmune and inflammatory diseases and conditions

#2128
20170260235
2017-09-14

POLYPEPTIDE EXPRESSED IN THE STRATUM CORNEUM AND USE THEREOF

#2129
20170258928
2017-09-14

Cell penetrating peptides for intracellular delivery of molecules

#2130
20170253908
2017-09-07

Quantification of vaccine compositions

#2131
20170253873
2017-09-07

Polypeptide inhibitors of Smad3 polypeptide activities

#2132
20170253646
2017-09-07

Functional Peptide Analogs of PEDF

#2133
20170253633
2017-09-07

Peptides, combination of peptides, and cell based medicaments for use in immunotherapy against urinary bladder cancer and other cancers

#2134
20170253632
2017-09-07

Inhibition of pulmonary fibrosis with nutlin-3a and peptides

#2135
20170252432
2017-09-07

Immunomodulators

#2136
20170247672
2017-08-31

Method for efficient delivery of therapeutic molecules in vitro and in vivo

#2137
20170247434
2017-08-31

Norovirus antibodies

#2138
20170247423
2017-08-31

STAPLED INTRACELLULAR-TARGETING ANTIMICROBIAL PEPTIDES TO TREAT INFECTION

#2139
20170247422
2017-08-31

EXTRACELLULAR MATRIX METALLOPROTEINASE INDUCER (EMMPRIN) PEPTIDES AND BINDING ANTIBODIES

#2140
20170247414
2017-08-31

Anti-microbial peptides

#2141
20170247413
2017-08-31

Compstatin analogs with improved pharmacokinetic properties

#2142
20170246324
2017-08-31

Peptide reagents and methods for detection and targeting of dysplasia, early cancer and cancer

#2143
20170246311
2017-08-31

PEPTIDES FOR BINDING ALTERNATIVELY ACTIVATED MACROPHAGES

#2144
20170246266
2017-08-31

Cell penetrating peptide, conjugate thereof with botulinum toxin, and use thereof

#2145
20170240599
2017-08-24

Process for the preparation of linaclotide

#2146
20170240598
2017-08-24

Advanced macromolecule transduction domain (aMTD) sequences for improvement of cell-permeability, polynucleotides encoding the same, method to identify the unique features of aMTDs comprising the same, method to develop the aMTD sequences comprising the same

#2147
20170240597
2017-08-24

In vivo methods of monitoring biodistribution

#2148
20170240596
2017-08-24

Prostate-specific membrane antigen (PSMA) targeting peptides

#2149
20170240594
2017-08-24

Therapeutic Use of Peptide Inhibitors of NADPH Oxidase; Aerosolization as a Delivery Mechanism

#2150
20170239364
2017-08-24

Methods and compositions related to inhibition of viral entry

#2151
20170233747
2017-08-17

Targeted/TGF-ßRII fusion proteins and methods for making same

#2152
20170232088
2017-08-17

Telomerase polypeptide vaccine for treating cancer

#2153
20170232087
2017-08-17

Telomerase polypeptide vaccine for treating cancer

#2154
20170232085
2017-08-17

Method for minimising progression of cancer in companion animals

#2155
20170226559
2017-08-10

Markers for mood disorders

#2156
20170226190
2017-08-10

Metallothionein-derived peptide fragments

#2157
20170226168
2017-08-10

Cell-permeable (ICP)-SOCS3 recombinant protein and uses thereof

#2158
20170226157
2017-08-10

COMPOSITIONS AND METHODS FOR THE TREATMENT OF OCULAR DISEASES

#2159
20170226156
2017-08-10

Methods for inhibiting immune complex formation in a subject

#2160
20170226152
2017-08-10

Solid phase peptide synthesis

#2161
20170218027
2017-08-03

Functional lipid constructs

#2162
20170218023
2017-08-03

SYNTHETIC ANALOGUES OF NEURAL REGENERATION PEPTIDES

#2163
20170218022
2017-08-03

Targeted conformationally-constrained kinked endosomal disrupting peptides

#2164
20170218021
2017-08-03

Botulinum neurotoxin-specific capture agents, compositions, and methods of using and making

#2165
20170218019
2017-08-03

Peptide for inducing multinucleation in cells, and use therefor

#2166
20170218017
2017-08-03

Melanocortin 1 receptor ligands and methods of use

#2167
20170212120
2017-07-27

Selected reaction monitoring assays

#2168
20170210777
2017-07-27

Antibody-binding polypeptide, antibody-binding fusion polypeptide, and adsorption material

#2169
20170209590
2017-07-27

Methods and reagents for efficient and targeted delivery of therapeutic molecules to CXCR4 cells

#2170
20170209531
2017-07-27

Agonists of guanylate cyclase useful for the treatment of gastrointestinal disorders, inflammation, cancer and other disorders

#2171
20170204153
2017-07-20

Method of designing a peptide and/or peptide derivative for modulating gamma-c-cytokine activity

#2172
20170204146
2017-07-20

Antimicrobial peptides

#2173
20170204140
2017-07-20

ANTAGONISTIC PEPTIDES

#2174
20170204139
2017-07-20

Matriptase and u-plasminogen activator substrates and other cleavable moieties and methods of use thereof

#2175
20170202986
2017-07-20

Sterilization and filtration of peptide compositions

#2176
20170202904
2017-07-20

Formulations of guanylate cyclase C agonists and methods of use

#2177
20170202903
2017-07-20

Formulations of guanylate cyclase C agonists and methods of use

#2178
20170199199
2017-07-13

Compositions and methods for regulating glucose metabolism

#2179
20170198019
2017-07-13

CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF

#2180
20170198011
2017-07-13

COMPOSITION FOR TREATING SEPSIS OR SEPTIC SHOCK COMPRISING THE PEPTIDE ORIGINATED FROM THE SMAD6

#2181
20170196956
2017-07-13

KIF20A epitope peptides for TH1 cells and vaccines containing the same

#2182
20170190760
2017-07-06

Polypeptides derived from calcitonin receptors and methods of use

#2183
20170190754
2017-07-06

Cell-permeable (iCP)-SOCS3 recombinant protein and uses thereof

#2184
20170190746
2017-07-06

RECOMBINANT POLYPEPTIDE FOR PROMOTING SCARLESS WOUND HEALING AND BIOADHESIVE MATERIAL INCLUDING THE SAME

#2185
20170190741
2017-07-06

COMPSTATIN ANALOGS WITH IMPROVED ACTIVITY

#2186
20170189531
2017-07-06

Composition and methods for tethering bioactive peptides to metal oxide surfaces

#2187
20170189513
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2188
20170189512
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2189
20170189511
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2190
20170189510
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2191
20170189506
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2192
20170189505
2017-07-06

Peptides and combination of peptides for use in immunotherapy against various cancers

#2193
20170183710
2017-06-29

Tyrosine kinase biosensors and methods of use

#2194
20170183639
2017-06-29

Cardiotonic steroid antagonists and related methods

#2195
20170183392
2017-06-29

Compositions and methods for increasing the expression and signalling of proteins on cell surfaces

#2196
20170183381
2017-06-29

NOVEL PEPTIDES FOR PREVENTING OR TREATING BONE DISEASES AND USE THEREOF

#2197
20170183380
2017-06-29

Cancer targeting by anti-EGFR peptides and applications thereof

#2198
20170183379
2017-06-29

Drug delivery enhancement agents

#2199
20170174727
2017-06-22

TFPI inhibitors and methods of use

#2200
20170174724
2017-06-22

Biologically active peptides

#2201
20170173132
2017-06-22

Peptides and combination of peptides for use in immunotherapy against breast cancer and other cancers

#2202
20170173131
2017-06-22

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#2203
20170173125
2017-06-22

Isolated donor MHC-derived peptide and uses thereof

#2204
20170173107
2017-06-22

Compstatin analogs with improved potency and pharmacokinetic properties

#2205
20170172139
2017-06-22

Method for treating blood, blood products and organs

#2206
20170165340
2017-06-15

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#2207
20170165338
2017-06-15

Peptides and combination of peptides for use in immunotherapy against various cancers

#2208
20170165337
2017-06-15

Peptides and combination of peptides for use in immunotherapy against CLL and other cancers

#2209
20170165320
2017-06-15

Targeting of PELP1 in cancer therapy

#2210
20170165319
2017-06-15

β-hairpin peptidomimetics

#2211
20170158745
2017-06-08

IDR PEPTIDE COMPOSITIONS AND USE THEREOF FOR TREATMENT OF TH2-DYSREGULATED INFLAMMATORY CONDITIONS

#2212
20170158744
2017-06-08

Mimotopes of alpha-synuclein and vaccines thereof for the treatment of neurodegenerative disorders

#2213
20170158738
2017-06-08

Multiplexed same type-antigenic peptide

#2214
20170158736
2017-06-08

Compositions and methods for treating MRSA infections and for sensitizing MRSA to beta-lactam antibiotics

#2215
20170158731
2017-06-08

Nucleophile-reactive sulfonated compounds for the (radio)labelling of (bio)molecules; precursors and conjugates thereof

#2216
20170157227
2017-06-08

Mucin-associated surface protein as a vaccine against chagas disease

#2217
20170157199
2017-06-08

Lytic-peptide-Her2/neu (Human Epidermal growth factor Receptor 2) ligand conjugates and methods of use

#2218
20170157198
2017-06-08

TFPI inhibitors and methods of use

#2219
20170153228
2017-06-01

Substrates for detection of botulinum neurotoxin

#2220
20170152290
2017-06-01

Beta hairpin peptides having antiviral properties against Dengue virus

#2221
20170146550
2017-05-25

Lysine monomethylated derivative and corresponding antibody and use thereof

#2222
20170146522
2017-05-25

Peptide tag system that spontaneously form an irreversible link to protein partners via isopeptide bonds

#2223
20170145083
2017-05-25

Phoenixin peptides

#2224
20170145057
2017-05-25

Antimicrobial peptides, pharmaceutical compositions, and methods of use thereof

#2225
20170145047
2017-05-25

Diarylsulfide backbone containing photolabile protecting groups

#2226
20170143810
2017-05-25

IMMUNOGENIC GLYCOPEPTIDES, COMPOSITION COMPRISING THE GLYCOPEPTIDES AND USE THEREOF

#2227
20170137482
2017-05-18

CELL-PERMEABLE (ICP)-SOCS3 RECOMBINANT PROTEIN AND USES THEREOF

#2228
20170137471
2017-05-18

Antimicrobial peptide dendrimers

#2229
20170137468
2017-05-18

Modulation of complement activity

#2230
20170137467
2017-05-18

Epitope tag and method for detection and/or purification of tagged polypeptides

#2231
20170137464
2017-05-18

Antibody, epitope tag and method for detection, capture and/or purification of tagged polypeptides

#2232
20170136108
2017-05-18

NOVEL PEPTIDES, COMBINATION OF PEPTIDES AND SCAFFOLDS FOR USE IN IMMUNOTHERAPEUTIC TREATMENT OF VARIOUS CANCERS

#2233
20170129942
2017-05-11

Antibody molecule-drug conjugates and uses thereof

#2234
20170129934
2017-05-11

Natriuretic polypeptides

#2235
20170129925
2017-05-11

Process of preparing guanylate cyclase C agonisys

#2236
20170129924
2017-05-11

Peptides with antimicrobial, anticancer and/or wound-healing promoting activities, pharmaceutical compositions containing the same, and use of the peptides with antimicrobial, anticancer and/or wound-healing promoting activities

#2237
20170128558
2017-05-11

Anti-malaria compositions and methods

#2238
20170121676
2017-05-04

Methods and compositions for targeting progenitor cell lines

#2239
20170121370
2017-05-04

Antibody/drug conjugates and methods of use

#2240
20170119845
2017-05-04

Chloride salt of TAT-NR2B9c

#2241
20170114100
2017-04-27

TARGETING DIMERIZATION OF BAX TO MODULATE BAX ACTIVITY

#2242
20170114097
2017-04-27

Compositions and Methods of Treatment of Cancers

#2243
20170114096
2017-04-27

ANTIBIOTIC PEPTIDES

#2244
20170112942
2017-04-27

Cell penetrating peptide, conjugate comprising same, and composition comprising conjugate

#2245
20170107259
2017-04-20

Template-fixed peptidomimetics with antimicrobial activity

#2246
20170107256
2017-04-20

Modified apidaecin derivatives as antibiotic peptides

#2247
20170107255
2017-04-20

Apelin polypeptides

#2248
20170107254
2017-04-20

Modified Antimicrobial Peptides

#2249
20170106106
2017-04-20

Multidentate bifunctional chelating agents for radionuclide complexation in diagnostics and therapy

#2250
20170106053
2017-04-20

ACTH prophylactic treatment of renal disorders

#2251
20170106042
2017-04-20

METHODS AND COMPOSITIONS FOR MODULATING HGF/MET

#2252
20170101442
2017-04-13

Peptide ligands for hepatic stellate cells

#2253
20170101441
2017-04-13

Chemical and biochemical adducts as biomarkers for organophosphate exposure

#2254
20170097349
2017-04-06

Diagnostic reagents

#2255
20170096461
2017-04-06

Peptides and combination of peptides for use in immunotherapy against small cell lung cancer and other cancers

#2256
20170096452
2017-04-06

Tumor-targeting compounds

#2257
20170095581
2017-04-06

Bispecific peptide conjugate and radioactive bispecific peptide imaging agent

#2258
20170088591
2017-03-30

Modified antibiotic peptides having variable systemic release

#2259
20170088584
2017-03-30

USE OF PEPTIDIC DRUGS FOR OSTEOPOROSIS TREATMENT AND BONE REGENERATION

#2260
20170088582
2017-03-30

Macrocyclic broad spectrum antibiotics

#2261
20170081661
2017-03-23

Cell penetrating peptides for intracellular delivery of molecules

#2262
20170081649
2017-03-23

Production of highly thermally stable recombinant cholinesterases for the detection, detoxification and decontamination of organophosphorus compounds

#2263
20170081397
2017-03-23

Modified antibody containing the cleavable peptide with the amino acid sequence TGRGPSWV

#2264
20170081377
2017-03-23

RTEF-1 variants and the use thereof for inhibition of angiogenesis

#2265
20170081376
2017-03-23

Anti-inflammatory peptides and composition comprising the same

#2266
20170081367
2017-03-23

Peptides for preventing or treating bone diseases and use thereof

#2267
20170081366
2017-03-23

Novel Peptides for Preventing or Treating Bone Diseases and Use Thereof

#2268
20170074858
2017-03-16

Stabilizied bioactive peptides and methods of identification, synthesis and use

#2269
20170073384
2017-03-16

Methods and compositions for treating neurodegenerative disorders and alzheimer's disease and improving normal memory

#2270
20170073372
2017-03-16

Anti-lymphoma peptides

#2271
20170072037
2017-03-16

Xenoantigen-displaying anti-cancer vaccines and method of making

#2272
20170066825
2017-03-09

Erythrocyte-binding therapeutics

#2273
20170066801
2017-03-09

ALPHA3BETA HYDROGEN BOND SURROGATE MACROCYCLES AS MODULATORS OF RAS

#2274
20170066799
2017-03-09

Stitched polypeptides

#2275
20170061288
2017-03-02

In silico design of peptides equilibrated in a lipid bilayer with partition free energies indicating probability of antimicrobial activity

#2276
20170058050
2017-03-02

Covalently linked helicar-anti-helicar antibody conjugates and uses thereof

#2277
20170058001
2017-03-02

Composition for organ, tissue, or cell transplantation, kit, and transplantation method

#2278
20170058000
2017-03-02

Bioactive peptide complexes

#2279
20170057999
2017-03-02

Peptides for treating cancer

#2280
20170057998
2017-03-02

Antimicrobial surface

#2281
20170056521
2017-03-02

Fusion protein for treating rejection reaction in transplantation

#2282
20170056520
2017-03-02

Multi-arm linker for treating rejection reaction in transplantation

#2283
20170056515
2017-03-02

Compositions and methods for transport across the blood brain barrier

#2284
20170056488
2017-03-02

Peptides, combination of peptides and scaffolds for use in immunotherapeutic treatment of various cancers

#2285
20170056486
2017-03-02

Method for treating cancer with activated T cells

#2286
20170056470
2017-03-02

Peptides of syndecan-1 for inhibiting angiogenesis

#2287
20170056466
2017-03-02

JNK inhibitor molecules for treatment of various diseases

#2288
20170055505
2017-03-02

Rodent model of prostate cancer

#2289
20170051016
2017-02-23

ANTI-INFLAMMATORY NANOFIBERS

#2290
20170051015
2017-02-23

Methods of developing selective peptide antagonists

#2291
20170044236
2017-02-16

Integrin Antagonists

#2292
20170044214
2017-02-16

Selective delivery molecules and methods of use

#2293
20170042975
2017-02-16

Peptides for the treatment of cancer

#2294
20170042960
2017-02-16

Compositions and methods for treating hepatitis B

#2295
20170037484
2017-02-09

variant and method for producing daptomycin using same

#2296
20170037389
2017-02-09

Polypeptides having cellobiohydrolase activity and polynucleotides encoding same

#2297
20170037110
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2298
20170037107
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2299
20170037098
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2300
20170037097
2017-02-09

Peptides and combination of peptides for use in immunotherapy against non-small cell lung cancer and other cancers

#2301
20170037096
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2302
20170037095
2017-02-09

Method for treating cancer with an activated T lymphocyte that selectively recognizes a cancer cell consisting of specific peptide

#2303
20170037094
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2304
20170037093
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2305
20170037092
2017-02-09

Peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2306
20170037085
2017-02-09

Peptidomimetic compounds

#2307
20170037084
2017-02-09

Macrocyclic peptidomimetics for alpha-helix mimicry

#2308
20170035902
2017-02-09

COMPOSITIONS AND METHODS FOR TISSUE REPAIR

#2309
20170035835
2017-02-09

Peptides and methods of use

#2310
20170035830
2017-02-09

Compositions and methods for treating heart disease and/or injury

#2311
20170035807
2017-02-09

Peptides and combination of peptides for use in immunotherapy against epithelial ovarian cancer and other cancers

#2312
20170029812
2017-02-02

GENETICALLY ENGINEERED POLYMER LIBRARIES AND METHODS OF USING THEM

#2313
20170029483
2017-02-02

Murine anti-NY-ESO-1 T cell receptors

#2314
20170029468
2017-02-02

AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS

#2315
20170029467
2017-02-02

METHOD OF PRODUCING BIVALIRUDIN

#2316
20170029466
2017-02-02

Peptides whose uptake by cells is controllable

#2317
20170029465
2017-02-02

Peptides and methods of using same

#2318
20170028053
2017-02-02

Peptide sequences and compositions

#2319
20170028019
2017-02-02

Suppression of allergic lung inflammation and hyperreactivity

#2320
20170022251
2017-01-26

Cell epitopes and combination of cell epitopes for use in the immunotherapy of myeloma and other cancers

#2321
20170020956
2017-01-26

Peptides having anti-inflammatory properties

#2322
20170020953
2017-01-26

Methods for the treatment of depression and anxiety

#2323
20170020952
2017-01-26

Methods for the treatment of central nervous system (CNS) disorders and mood disorders

#2324
20170015991
2017-01-19

Hybrid polymers, pharmaceutical compositions and methods of synthesizing the same

#2325
20170015708
2017-01-19

CHEMOKINE BINDING POLYPEPTIDES FOR TREATING AUTOIMMUNITY, AND INFLAMMATION

#2326
20170009280
2017-01-12

Compositions and methods for recognition of RNA using triple helix forming peptide nucleic acids

#2327
20170008959
2017-01-12

AGER-PEPTIDES AND USE THEREOF

#2328
20170008939
2017-01-12

Non-narcotic CRMP2 peptides targeting sodium channels for chronic pain

#2329
20170008930
2017-01-12

STABILIZED ALPHA HELICAL PEPTIDES AND USES THEREOF

#2330
20170008929
2017-01-12

SOCS mimetics for the treatment of diseases

#2331
20170008928
2017-01-12

NOVEL PEPTIDES AND PEPTIDE DERIVATIVES AND USES THEREOF

#2332
20170008926
2017-01-12

Rare earth material-binding peptide and use thereof

#2333
20170007696
2017-01-12

Supramolecular hydrogel of fMLF-based molecules and use thereof

#2334
20170002055
2017-01-05

Novel peptides and combination of peptides for use in immunotherapy against ovarian cancer and other cancers

#2335
20170002050
2017-01-05

EphA2 T-cell epitope agonists and uses therefore

#2336
20170002049
2017-01-05

Compositions and methods of using islet neogenesis peptides and analogs thereof

#2337
20170002047
2017-01-05

Plant-derived elastin binding protein ligands and methods of using the same

#2338
20170002042
2017-01-05

Peptidomimetic macrocycles

#2339
20170000904
2017-01-05

PHARMACOLOGICALLY INDUCED TRANSGENE ABLATION SYSTEM

#2340
20170000843
2017-01-05

Compositions useful for the treatment of gastrointestinal disorders

#2341
20160376346
2016-12-29

Fc fusion proteins comprising novel linkers or arrangements

#2342
20160376336
2016-12-29

Engineered potent cytotoxic stapled BH3 peptides

#2343
20160376335
2016-12-29

POLYMERS CONTAINING MULTIVALENT AMYLOID-BETA-BINDING D-PEPTIDES AND THEIR USE

#2344
20160376322
2016-12-29

Derivative peptide compounds and methods of use

#2345
20160376320
2016-12-29

Anti-microbial peptides and method for designing novel anti-microbial peptides

#2346
20160376319
2016-12-29

Collagen imaging compositions

#2347
20160376318
2016-12-29

POLYPEPTIDE, DNA MOLECULE ENCODING THE POLYPEPTIDE, VECTOR, PREPARATION METHOD AND USE

#2348
20160376317
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2349
20160376316
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2350
20160376315
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2351
20160376314
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2352
20160376313
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2353
20160376312
2016-12-29

Immunotherapy against several tumors including neuronal and brain tumors

#2354
20160375155
2016-12-29

Collagen Imaging Compositions

#2355
20160375092
2016-12-29

Peptide and a use thereof

#2356
20160375091
2016-12-29

Composition for treating prostate cancer

#2357
20160369250
2016-12-22

Neurodegenerative disorders

#2358
20160368948
2016-12-22

IMMUNOGENIC WT-1 PEPTIDES AND METHODS OF USE THEREOF

#2359
20160367694
2016-12-22

Peptide having cancer selective translocation function and use thereof

#2360
20160367691
2016-12-22

TARGETED ENZYME COMPOUNDS AND USES THEREOF

#2361
20160362471
2016-12-15

Artificial signal peptide

#2362
20160362466
2016-12-15

Peptides having osteoblast growth-promoting activity and use thereof

#2363
20160362465
2016-12-15

WT1 antigenic polypeptide, and anti-tumor agent containing said polypeptide

#2364
20160362454
2016-12-15

Identification and attenuation of the immunosuppressive domains in fusion proteins of enveloped RNA viruses

#2365
20160362451
2016-12-15

Self-assembling peptide compositions

#2366
20160362445
2016-12-15

Solid phase peptide synthesis via side chain attachment

#2367
20160361434
2016-12-15

mTG substrates for covalent conjugation of compounds

#2368
20160361431
2016-12-15

Methods for reducing immune responses

#2369
20160360747
2016-12-15

Hypersensitive response elicitor peptides and use thereof

#2370
20160355592
2016-12-08

Anti-ITGA3 antibodies, activatable anti-ITGA3 antibodies, and methods of use thereof

#2371
20160355550
2016-12-08

Immunotherapy against several tumors including neuronal and brain tumors

#2372
20160355548
2016-12-08

Tumor-targeting polypeptide and application thereof

#2373
20160354484
2016-12-08

Compositions for inducing antigen-specific tolerance

#2374
20160354454
2016-12-08

Methods for induction of antigen-specific immune tolerance

#2375
20160354453
2016-12-08

Compositions for generating immune tolerance by targeting erythrocytes

#2376
20160353736
2016-12-08

Elicitor peptides having disrupted hypersensitive response box and use thereof

#2377
20160353735
2016-12-08

Elicitor peptides having disrupted hypersensitive response box and use thereof

#2378
20160353734
2016-12-08

Hypersensitive response elicitor peptides and use thereof

#2379
20160347810
2016-12-01

Compositions and methods for treating acute and chronic pain by local antagonism of CGRP receptors, or combination with sodium channel inhibition or with anti-inflammatory agents

#2380
20160346411
2016-12-01

Activatable fibrin-binding probes

#2381
20160346383
2016-12-01

Ezrin-derived peptides and pharmaceutical compositions thereof

#2382
20160341744
2016-11-24

Pharmaceutical compositions containing peptides derived from human BPLP protein

#2383
20160340391
2016-11-24

Macrocyclic inhibitors of the PD-1/PD-L1 and CD80(B7-1)/PD-L1 protein/protein interactions

#2384
20160340390
2016-11-24

AGONISTS OF GUANYLATE CYCLASE USEFUL FOR THE TREATMENT OF GASTROINTESTINAL DISORDERS, INFLAMMATION, CANCER AND OTHER DISORDERS

#2385
20160339116
2016-11-24

Molecular constructs with targeting and effector moieties for treating infectious diseases

#2386
20160339115
2016-11-24

Molecular constructs with targeting and effector moieties comprising an SCFV specific for ectodomain of transferrin-1 receptor and fingolimod

#2387
20160339111
2016-11-24

Peptide core-based multi-arm linkers for treating infectious diseases

#2388
20160339110
2016-11-24

Peptide core-based multi-arm linkers for treating central nervous system diseases

#2389
20160339109
2016-11-24

Peptide core-based multi-arm linkers and their applications

#2390
20160333105
2016-11-17

Multivalent antibodies

#2391
20160333052
2016-11-17

Cross-linked peptides containing non-peptide cross-linked structure, method for synthesizing cross-linked peptides, and novel organic compound used in method

#2392
20160333051
2016-11-17

Template-fixed beta-hairpin peptidomimetics with protease inhibitory activity

#2393
20160333049
2016-11-17

Peptidomimetic macrocycles and uses thereof

#2394
20160331805
2016-11-17

Treatment of ocular disorders with anti-connexin proteins and mimetics

#2395
20160331804
2016-11-17

Selectively targeted antimicrobial peptides and the use thereof

#2396
20160331803
2016-11-17

VISTA antagonist and methods of use

#2397
20160326217
2016-11-10

Methods and Compositions Related to Cyclic Peptide Synthesis

#2398
20160324976
2016-11-10

Peptide having cell membrane penetrating activity

#2399
20160324937
2016-11-10

Fragments of P97 and uses thereof

#2400
20160318981
2016-11-03

Polypeptides targeting glycosylated MUC2 proteins, methods of synthesis, their nucleic acids and uses thereof